Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Steinhubl, Steven
  • Talley, J. D.
  • Braden, G. A.
  • Tcheng, J. E.
  • Casterella, P. J.
  • Moliterno, D. J.
  • Navetta, F. I.
  • Berger, P. B.
  • Popma, J. J.
  • Dangas, G.
  • Gallo, R.
  • Sane, D. C.
  • Saucedo, J. F.
  • Jia, G.
  • Lincoff, A. M.
  • Theroux, P.
  • Holmes, D. R.
  • Teirstein, P. S.
  • Kereiakes, D. J.

publication date

  • May 2001

journal

  • Circulation  Journal

subject areas

  • Aged
  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Blood Platelets
  • Cohort Studies
  • Female
  • Heart Diseases
  • Humans
  • Immunoglobulin Fab Fragments
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Peptides
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Prospective Studies
  • Risk Factors
  • Time Factors
  • Tyrosine
scroll to property group menus

Research

keywords

  • angioplasty
  • complications
  • platelets
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0009-7322

PubMed ID

  • 11382726
scroll to property group menus

Additional Document Info

start page

  • 2572

end page

  • 2578

volume

  • 103

issue

  • 21

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support